Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Olema Pharmaceuticals, Inc. | tmb-20201231xex32d1.htm |
| EX-31.2 - EX-31.2 - Olema Pharmaceuticals, Inc. | tmb-20201231xex31d2.htm |
| EX-31.1 - EX-31.1 - Olema Pharmaceuticals, Inc. | tmb-20201231xex31d1.htm |
| EX-23.1 - EX-23.1 - Olema Pharmaceuticals, Inc. | tmb-20201231xex23d1.htm |
| EX-21.1 - EX-21.1 - Olema Pharmaceuticals, Inc. | tmb-20201231xex21d1.htm |
| EX-4.3 - EX-4.3 - Olema Pharmaceuticals, Inc. | tmb-20201231xex4d3.htm |
| 10-K - 10-K - Olema Pharmaceuticals, Inc. | tmb-20201231x10k.htm |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Olema Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 17, 2021 | By: | /s/ Shane Kovacs |
| | Shane Kovacs |
| | Chief Operating and Financial Officer |
| | (Principal Financial Officer) |